Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  News


Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesHot NewsMost Read NewsRecomm.Business LeadersCalendar 

Johnson & Johnson Innovation Announces Collaborations with Two Canadian Early-Stage Drug Technology Development Centers

share with twitter share with LinkedIn share with facebook
share via e-mail
12/10/2013 | 02:09pm CEST

Johnson & Johnson Innovation and its affiliate Janssen Inc. in Canada today announced new collaborations with two Canadian early-stage drug technology development centers, Montreal-based NEOMED and Toronto-based MaRS Innovation, to identify and advance promising bio/pharmaceutical technologies that have the potential to impact human health.

Through these collaborations, technical experts from the Johnson & Johnson Innovation Center in Boston, Massachusetts will work with NEOMED and MaRS Innovation to identify investment opportunities emerging from well-validated scientific research discoveries within their communities of academic institutions and biotechnology companies.

"We know from our history of engagement that the Canadian bio/pharmaceutical environment is one of the most vibrant in the world," said Robert Urban, Head of the Johnson & Johnson Innovation Center, Boston. "These new collaborations will allow us to potentially advance important new clinical candidates against disease."

"Quebec and Ontario are home to numerous world-class academic and biomedical research enterprises," said Paul Kershaw, Vice President of Medical Affairs, Janssen Inc. in Canada. "These new relationships with NEOMED and MaRS Innovation are an extension of our commitment to Canada's innovative research community."

NEOMED is a not-for-profit, public-private Pharma alliance dedicated to drug discovery and development. Partially funded by the Ministère des Finances et de l'Économie du Québec, NEOMED is within the NEOMED Institute, a state-of-the-art R&D facility in the Montréal Technoparc.

MaRS Innovation is the commercialization agent for Ontario's discovery pipeline from 16 leading academic institutions. MaRS Innovation is supported by the Government of Canada through the Networks of Centres of Excellence, by the Government of Ontario through the Ontario Centres of Excellence, and by its 16 member institutions.

About Johnson & Johnson Innovation

The Boston Innovation Center is part of Johnson & Johnson Innovation, a division of Johnson & Johnson Finance Corporation. Johnson & Johnson Innovation focuses on accelerating early innovation and enhancing opportunities for collaboration and investment across Johnson & Johnson's global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies focused on early-stage opportunities a one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and diagnostics and consumer companies of Johnson & Johnson. Johnson & Johnson Innovation includes local deal-making capabilities with the flexibility to adapt deal structures to match early-stage opportunities and establish novel collaborations that speed development of those innovations to solve unmet needs in patients. Follow us @jnjinnovation on Twitter. Please visit www.jnjinnovation.com for more information.

About Janssen Inc.

Janssen is dedicated to addressing and solving some of the most important unmet medical needs of our time in oncology, immunology, neuroscience, infectious diseases and vaccines, metabolic and chronic diseases and women's health. Driven by our commitment to patients, we bring innovative products, services and solutions to people throughout the world. Janssen Inc. in Canada is part of the Janssen Pharmaceutical Companies of Johnson & Johnson. Please visit http://www.janssen.ca for more information.

Johnson & Johnson
John Lacey, 781-392-5514
Feinstein Kean Healthcare
Jessica Rowlands, 202-729-4089

© Business Wire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news
Date Title
04:51p COMPUTER SERVICES : Strengthen Your Offense to Put a Hold on Cyberattacks
04:51p UKRSOTSBANK : UniCredit Bank gives 8 free trips in the subway for a month
04:51p ENTREPRENEURIALLY THINKING PODCAST : CAAAB’s Eddie Davis and Minority Entrepreneurship
04:51p ALSTRIA OFFICE REIT : Deutsche Office sells EUR 116.7 m of non-core assets
04:51p WEICHAI POWER : Overseas Regulatory Announcement—Third Quarterly Report For 2016 (Full Report)
04:51p LLOYDS BANKING : Euro Senior Notes Exchange Offer
04:51p LADBROKES : Publication of a Prospectus
04:51p AVICHINA INDUSTRY & TECHNOLOGY : Announcement results of subsidiaries
04:51p EMC : Nutanix looks to leverage Dell partnership post-EMC merger
Latest news
Hot News 
-7.00%Brexit dents Swiss engineer ABB's orders and outlook
-9.77%ARCADIS : CEO of engineering firm Arcadis quits after profit fall
-20.58%AMEC FOSTER WHEELER : unnerves investors as it postpones capital markets day
-5.34%BUCHER INDUSTRIES : Brexit vote hits Bucher's street and sewer cleaning sales
-3.40%SCHNEIDER ELECTRIC : sees Brexit impact in coming quarters
Most Read News
08:20a European banks reassure on earnings, dollar holds near highs
07:44a VOLKSWAGEN : VW brand profit plunges, Porsche lifts group
06:07a NISSAN MOTOR : UK car exports offset domestic drop in September output rise
02:44a Telefonica will decide on O2 listing when markets steady - UK CEO
10/26 China courier ZTO delivers year's biggest U.S. IPO
Most recommended articles
10/26DJS&P 500, Nasdaq Futures -- Technical Analysis
10/25 DEUTSCHE BANK : Schaeuble says monetary policy has reached its limits
10/25 APPLE : Gadgets in decline as R&D shifts to software and services - study
10/24DJGold Prices Turn Lower Amid Strong Economic Data